These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1715293)

  • 1. A 64 kDa protein from Mycobacterium bovis BCG shares the same antigenic determinants with line 10 hepatoma cells and has anti-line 10 tumor activity.
    Ahsan CR; Sasaki J
    FEBS Lett; 1991 Aug; 288(1-2):77-80. PubMed ID: 1715293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Mycobacterium bovis BCG 64-kDa surface protein is antigenically shared with different mouse tumor cells and has anti-tumor activity in immunized mice.
    Ahsan CR; Sasaki J
    Immunol Lett; 1993 Jun; 36(3):235-8. PubMed ID: 7690342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic analysis between BCG and tumor cells by BCG-monoclonal antibodies.
    Sasaki J; Kitagawa M; Tamagake T; Narita S; Ahsan CR; Lu CL
    Microbiol Immunol; 1989; 33(11):951-5. PubMed ID: 2687649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a Mycobacterium bovis BCG 45/47-kilodalton antigen complex, an immunodominant target for antibody response after immunization with living bacteria.
    Romain F; Laqueyrerie A; Militzer P; Pescher P; Chavarot P; Lagranderie M; Auregan G; Gheorghiu M; Marchal G
    Infect Immun; 1993 Feb; 61(2):742-50. PubMed ID: 8423100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brief communication: antigenic relationship between Mycobacterium bovis (BCG) and a guinea pig hepatoma.
    Borsos T; Rapp HJ
    J Natl Cancer Inst; 1973 Sep; 51(3):1085-6. PubMed ID: 4355214
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunoelectronmicroscopic analysis of surface antigens common to Mycobacterium bovis (BCG) and tumor cells.
    Bucana C; Hanna MG
    J Natl Cancer Inst; 1974 Nov; 53(5):1313-23. PubMed ID: 4139279
    [No Abstract]   [Full Text] [Related]  

  • 7. Shared antigens between human malignant melanoma cells and Mycobacterium bovis (BCG).
    Minden P; Sharpton TR; McClatchy JK
    J Immunol; 1976 May; 116(5):1407-14. PubMed ID: 58033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic characterization of Mycobacterium bovis BCG culture filtrate.
    Gupta VK; Ram GC; Bansal MP
    Vet Microbiol; 1994 Aug; 41(4):345-53. PubMed ID: 7801534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression and immunotherapy of the guinea pig line 10 hepatocarcinoma mediated by heat-killed disrupted Mycobacterium bovis strain Bacillus Calmette-Guérin.
    Minden P; Mathews HL
    Cancer Res; 1980 Sep; 40(9):3214-7. PubMed ID: 6159072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shared antigens between Mycobacterium bovis (BCG) and neoplastic cells.
    Minden P; McClatchy JK; Wainberg M; Weiss DW
    J Natl Cancer Inst; 1974 Nov; 53(5):1325-31. PubMed ID: 4139280
    [No Abstract]   [Full Text] [Related]  

  • 11. Suppression of the line-10 guinea pig hepatocarcinoma by antigens related to both Mycobacterium bovis (BCG) and the tumor.
    Minden P; Mathews HL; Kelleher PJ
    J Immunol; 1980 Dec; 125(6):2685-9. PubMed ID: 7000904
    [No Abstract]   [Full Text] [Related]  

  • 12. [Purification, characterization and immunological study of 2 protein antigens of the BCG strain Mycobacterium bovis].
    De Bruyn J; Turneer M
    Bull Mem Acad R Med Belg; 1988; 143(1-2):157-70. PubMed ID: 3052672
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterization of the secreted antigens of Mycobacterium bovis BCG: comparison of the 46-kilodalton dimeric protein with proteins MPB64 and MPB70.
    Abou-Zeid C; Harboe M; Rook GA
    Infect Immun; 1987 Dec; 55(12):3213-4. PubMed ID: 3316036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of serologic and cell-mediated reactivity of a 38-kDa antigen isolated from Mycobacterium tuberculosis.
    Kadival GV; Chaparas SD; Hussong D
    J Immunol; 1987 Oct; 139(7):2447-51. PubMed ID: 2443566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor activity of mycobacterial glycolipid A1.
    Reggiardo Z
    Infect Immun; 1978 Sep; 21(3):914-7. PubMed ID: 81809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenic characterization of Mycobacterium bovis BCG soluble antigens.
    Gupta VK; Ram GC; Bansal MP
    Vet Microbiol; 1994 Jan; 38(3):227-40. PubMed ID: 8017027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of fibronectin-binding antigens released by Mycobacterium tuberculosis and Mycobacterium bovis BCG.
    Abou-Zeid C; Ratliff TL; Wiker HG; Harboe M; Bennedsen J; Rook GA
    Infect Immun; 1988 Dec; 56(12):3046-51. PubMed ID: 3141278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective localization of tumor-immune spleen cells at the tumor challenge site after adoptive transfer of line 10 tumor immunity in strain 2 guinea pigs.
    de Jong WH; van de Plas MM; Steerenberg PA; Kruizinga W; Ruitenberg EJ
    J Immunol; 1985 Mar; 134(3):2032-40. PubMed ID: 2578526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigenic relatedness of a strongly immunogenic 65 kDA mycobacterial protein antigen with a similarly sized ubiquitous bacterial common antigen.
    Thole JE; Hindersson P; de Bruyn J; Cremers F; van der Zee J; de Cock H; Tommassen J; van Eden W; van Embden JD
    Microb Pathog; 1988 Jan; 4(1):71-83. PubMed ID: 3143894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of isoniazid on BCG-mediated tumor immunity.
    Romolo JL; Loyd B; Cohen MH
    Surg Forum; 1977; 28():158-9. PubMed ID: 364713
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.